Arrowhead Pharmaceuticals, Inc. (0HI3.L)

USD 21.69

(-2.58%)

Long Term Debt Summary of Arrowhead Pharmaceuticals, Inc.

  • Arrowhead Pharmaceuticals, Inc.'s latest annual long term debt in 2023 was 104.6 Million USD , up 32.75% from previous year.
  • Arrowhead Pharmaceuticals, Inc.'s latest quarterly long term debt in 2024 Q3 was 336.03 Million USD , up 19.61% from previous quarter.
  • Arrowhead Pharmaceuticals, Inc. reported annual long term debt of 78.8 Million USD in 2022, up 238.27% from previous year.
  • Arrowhead Pharmaceuticals, Inc. reported annual long term debt of 23.29 Million USD in 2021, up 16.22% from previous year.
  • Arrowhead Pharmaceuticals, Inc. reported quarterly long term debt of 115.15 Million USD for 2024 Q1, down 0.0% from previous quarter.
  • Arrowhead Pharmaceuticals, Inc. reported quarterly long term debt of 280.93 Million USD for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Arrowhead Pharmaceuticals, Inc. (2023 - 1997)

Historical Annual Long Term Debt of Arrowhead Pharmaceuticals, Inc. (2023 - 1997)

Year Long Term Debt Long Term Debt Growth
2023 104.6 Million USD 32.75%
2022 78.8 Million USD 238.27%
2021 23.29 Million USD 16.22%
2020 20.04 Million USD 0.0%
2019 - USD -100.0%
2018 2.1 Million USD -9.63%
2017 2.32 Million USD -8.23%
2016 2.53 Million USD 368.47%
2015 540.79 Thousand USD -28.69%
2014 758.34 Thousand USD -31.75%
2013 1.11 Million USD -47.64%
2012 2.12 Million USD 249.69%
2011 606.78 Thousand USD 0.0%
2010 - USD -100.0%
2009 500 Thousand USD -31.18%
2008 726.53 Thousand USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD -100.0%
2002 27.5 Thousand USD -16.67%
2001 33 Thousand USD -15.38%
2000 39 Thousand USD -9.3%
1999 43 Thousand USD -86.19%
1998 311.43 Thousand USD 0.0%
1997 - USD 0.0%

Peer Long Term Debt Comparison of Arrowhead Pharmaceuticals, Inc.

Name Long Term Debt Long Term Debt Difference
Xeris Biopharma Holdings, Inc. 190.93 Million USD 45.212%
Codexis, Inc. 12.24 Million USD -754.431%
Viridian Therapeutics, Inc. 20.2 Million USD -417.733%
Organovo Holdings, Inc. 888 Thousand USD -11680.18%